The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A feasibility study of neoadjuvant talazoparib for early-stage breast cancer patients with a germline BRCA pathogenic variant: NCT02282345.
 
Jennifer Keating Litton
Consulting or Advisory Role - Medivation; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Genentech; medivation; Novartis; pfizer
Patents, Royalties, Other Intellectual Property - UptoDate
Travel, Accommodations, Expenses - Medivation
 
Marion Scoggins
No Relationships to Disclose
 
Gary J Whitman
No Relationships to Disclose
 
Carlos Hernando Barcenas
No Relationships to Disclose
 
Stacy L. Moulder
Honoraria - Novartis
Research Funding - Bayer (Inst); Genentech (Inst); Novartis (Inst); Oncothyreon (Inst); Pfizer (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Novartis
 
Rashmi Krishna Murthy
Consulting or Advisory Role - Daiichi Sankyo; Genentech
Research Funding - Merrimack (Inst); Oncothyreon (Inst)
Travel, Accommodations, Expenses - Genentech/Roche; Oncothyreon
 
Sausan Abouharb
No Relationships to Disclose
 
Beatriz Adrada
No Relationships to Disclose
 
Thorunn Helgason
No Relationships to Disclose
 
Jill Schwartz-Gomez
No Relationships to Disclose
 
Elizabeth Ann Mittendorf
Consulting or Advisory Role - Amgen; OBI Pharma
Research Funding - Antigen Express (Inst); Galena Biopharma (Inst); Genentech/Roche (Inst)
 
Alastair Mark Thompson
Travel, Accommodations, Expenses - Novartis (I)
 
Banu Arun
Consulting or Advisory Role - Abbvie